Bayer, the German aspirin to week killer conglomerate has made a $62bn all cash offer for Monsanto, the US agribusiness. If agreed, the deal would create a huge global company providing farmers with everything from seeds to crop chemicals. Matthew Vincent asks FT Berlin correspondent Guy Chazan and Chicago correspondent Lindsay Whipp, to assess what chance the megadeal has of going through.

iTunes Stitcher audioBoom SoundCloud Overcast RSS


Copyright The Financial Times Limited 2017. All rights reserved.
myFT

Follow the topics related to this show

Comments have not been enabled for this podcast.